Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one urotensin II receptor antagonists

Benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one urotensin II receptor antagonists

US Patent 8759342 · Granted Jun 24, 2014

Estimated economic value: $51,518,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Drug delivery and imaging chemical conjugate, formulations and methods of use th2025
Remodilins for airway remodeling and organ fibrosis2025
Deuterated compounds and uses thereof2025
Toxic aldehyde related diseases and treatment2024
Monocyclic and bicyclic ring system substituted carbanucleoside analogues for us2024
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inh2024
Deuterated compounds and uses thereof2023
Toxic aldehyde related diseases and treatment2023
Toxic aldehyde related diseases and treatment2023
Deuterated compounds and uses thereof2022
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inh2022
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and2022